Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy

Autor: Giovacchini G.1, 2, Picchio M. 3, 5, Parra R.G. 1, Briganti A. 4, Gianolli L. 3, Montorsi F. 4, Messa C. 1, 6

Publikováno v: Clinical nuclear medicine 37 (2012): 325–331.
info:cnr-pdr/source/autori:Giovacchini G.1,2, Picchio M. 3,5, Parra R.G. 1, Briganti A. 4, Gianolli L. 3, Montorsi F. 4, Messa C. 1,5,6/titolo:Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET%2FCT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy./doi:/rivista:Clinical nuclear medicine/anno:2012/pagina_da:325/pagina_a:331/intervallo_pagine:325–331/volume:37

PURPOSE: We previously showed that prostate-specific antigen (PSA) doubling time (PSADT) is a significant predictor of C choline positron emission tomography/computed tomography (PET/CT) findings in prostate cancer (PCa) patients. This study compared

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::7c6a60f4f869c5edc9e51341f60dd56c
http://www.cnr.it/prodotto/i/10571

Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study

Autor: Cozzarini C. 1, Fiorino C. 2, Di Muzio N. 1, Valdagni R. 3, Salonia A. 4, Alongi F. 1, Broggi S. 2, Guazzoni G. 4, Montorsi F. 4, Rigatti P. 4, Calandrino R. 2, Fazio F. 1, 5, 6

Publikováno v: Radiotherapy and oncology 88 (2008): 26–33.
info:cnr-pdr/source/autori:Cozzarini C. 1, Fiorino C. 2, Di Muzio N. 1, Valdagni R. 3, Salonia A. 4, Alongi F. 1, Broggi S. 2, Guazzoni G. 4, Montorsi F. 4, Rigatti P. 4, Calandrino R. 2, Fazio F. 1,5,6/titolo:Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study/doi:/rivista:Radiotherapy and oncology/anno:2008/pagina_da:26/pagina_a:33/intervallo_pagine:26–33/volume:88

PURPOSE: To report on planning and toxicity findings of hypofractionated adjuvant radiotherapy with helical Tomotherapy (HTT) after radical prostatectomy (RP) for prostate carcinoma (pCa). METHODS AND MATERIALS: Fifty consecutive patients submitted t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::89b1fa785bda977069eb3f372bc34c83
https://publications.cnr.it/doc/10379